Study Name Principal Investigator
A011106; ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: a phase III study Ghamande, Sharad
A011401; Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer Ghamande, Sharad
A011502: A randomized phase III double blinded placebo-controlled trial of aspirin as adjuvant therapy for node-positive, HER2 negative breast cancer: the ABC trial Ghamande, Sharad
Agenus C-550-01: A Phase 1/2, Open-Label, Multi-Arm Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of AGEN1884 in Combination with AGEN2034 in Subjects with Metastatic or Locally Advanced Solid Tumors, and Expansion into Select Solid Tumors Ghamande, Sharad
An Open-label, Randomized, Phase 2/3 Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction of Clinical Benefit With First-line Chemotherapy Plus Pembrolizumab in Participants With Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (TNBC) (KEYLYNK-009) (MK7339-009) Krutchik, Allan
Developmental Gene Discovery Project: Mapping and Identifying New Genes in Uterine and Vaginal Development; Identifying New Genes Causing Birth Defects in Children Layman, Lawrence
EA1131 A Randomized Phase III Post Operative Trial of Platinum Based Chemotherapy Vs. Capecitabine in Patients with Residual Triple-Negative Basal-Like Breast Cancer following Neoadjuvant Chemotherapy Ghamande, Sharad
EA4151; A Randomized Phase III Trial of Consolidation with Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs. Maintenance Rituximab Alone for Patients with Mantle Cell Lymphoma in Minimal Residual Disease-Negative First Complete Remission Ghamande, Sharad
Genetics of Delayed Puberty/ Genes Important in Puberty, Dual Functions of WDR11 in the Pathogenesis of Hypogonadotrophic Hypogonadism Layman, Lawrence
ONT-380-206: Phase 2 Randomized, Double-Blinded, Controlled Study of ONT-380 vs. Placebo in Combination with Capecitabine and Trastuzumab in Patients with Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma Parikh, Jigarkumar
S1415CD; A PRAGMATIC TRIAL TO EVALUATE A GUIDELINE-BASED COLONY STIMULATING FACTOR STANDING ORDER INTERVENTION AND TO DETERMINE THE EFFECTIVENESS OF COLONY STIMULATING FACTOR USE AS PROPHYLAXIS FOR PATIENTS RECEIVING CHEMOTHERAPY WITH INTERMEDIATE RISK FOR FEBRILE NEUTROPENIA –TRIAL ASSESSING CSF PRESCRIBING EFFECTIVENESS AND RISK (TRACER) Ghamande, Sharad
Understanding the Genetic Basis of Transgender Identity Layman, Lawrence
RESEARCH. INNOVATION. DISCOVERY.